Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stefano, Del Giacco"'
Autor:
Igor Portoghese, Melinda Siddi, Luchino Chessa, Giulia Costanzo, Vanessa Garcia-Larsen, Andrea Perra, Roberto Littera, Giada Sambugaro, Stefano Del Giacco, Marcello Campagna, Davide Firinu
Publikováno v:
Vaccines, Vol 11, Iss 2, p 273 (2023)
Vaccine hesitancy and conspiracy beliefs among healthcare workers (HCWs) represent operational priorities that require urgent attention. Identifying and classifying specific subpopulation of hesitancy is crucial to customize educational and intervent
Externí odkaz:
https://doaj.org/article/770cd95c973149fab4cf642d0ddf07a1
Autor:
Davide Firinu, Andrea Perra, Marcello Campagna, Roberto Littera, Federico Meloni, Francesca Sedda, Maria Conti, Giulia Costanzo, Monica Erbi, Gianmario Usai, Carlotta Locci, Mauro Giovanni Carta, Riccardo Cappai, Germano Orrù, Stefano Del Giacco, Ferdinando Coghe, Luchino Chessa
Publikováno v:
Vaccines, Vol 9, Iss 12, p 1478 (2021)
In several countries, thrombotic events after vaccination with ChAdOx1 nCoV-19 have led to heterologous messenger RNA (mRNA) boosting. We tested the antibody response to SARS-CoV-2 spike protein four weeks after heterologous priming with the ChAdOx1
Externí odkaz:
https://doaj.org/article/557824f4c7774853a23eb040811711c3
Autor:
Giulia Costanzo, Andrea Giovanni Ledda, Alessandra Ghisu, Matteo Vacca, Davide Firinu, Stefano Del Giacco
Publikováno v:
Vaccines, Vol 10, Iss 1, p 13 (2021)
Background: We here describe the case of a 71-year-old Caucasian woman previously diagnosed with Eosinophilic Granulomatosis with Polyangiitis (EGPA) that had been treated with Mepolizumab, an anti-IL5 monoclonal antibody, since 2019 with a good clin
Externí odkaz:
https://doaj.org/article/b5c9d5322fd9417bb6edda8ef21eec13
Autor:
Giulia Costanzo, Andrea Giovanni Ledda, Alessandra Ghisu, Matteo Vacca, Davide Firinu, Stefano Del Giacco
Publikováno v:
Vaccines, Vol 10, Iss 13, p 13 (2022)
Vaccines
Vaccines
Background: We here describe the case of a 71-year-old Caucasian woman previously diagnosed with Eosinophilic Granulomatosis with Polyangiitis (EGPA) that had been treated with Mepolizumab, an anti-IL5 monoclonal antibody, since 2019 with a good clin